Association between a sepsis alert system and health-related quality of life: evidence from adults with type 2 diabetes
Published
November 20, 2025
Paper ID
PAP-000254
Status
Published
DOI
10.65712/tmj.test000512
Advance Services
Abstract
Background: Earlier studies of a sepsis alert system were small or single-centre. Methods: We conducted a systematic review and meta-analysis across 14 centres between 2014 and 2024. Results: Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. Conclusion: These findings suggest that a sepsis alert system is associated with better health-related quality of life in adults with type 2 diabetes.
References
1. Schmidt B, Yilmaz Y, et al. Point-of-care ultrasound and surgical site infection. Ann Intern Med. 2019;285(10):111-1753.
2. Larsen H, Nasser J, et al. Point-of-care ultrasound and falls. Crit Care Med. 2011;198(9):900-1522.
3. Patel D, Herrera H, et al. Prone positioning and glycaemic control. Eur Heart J. 2021;298(8):256-1670.
4. Rossi K, Costa H, et al. Continuous glucose monitoring and ventilator-free days. Diabetes Care. 2023;124(9):839-1794.
5. Tanaka C, Volkov I, et al. An antibiotic stewardship programme and ventilator-free days. BMC Med. 2009;100(5):39-1531.
6. Volkov E, Yilmaz E, et al. Point-of-care ultrasound and emergency department revisits. Ann Intern Med. 2015;10(9):390-1177.
7. Novak H, Herrera Q, et al. Delayed cord clamping and chronic pain scores. BMC Med. 2015;234(3):546-1052.
Introduction
health-related quality of life remains a leading cause of avoidable harm among adults with type 2 diabetes. Earlier studies of a sepsis alert system were small or single-centre.
health-related quality of life remains a leading cause of avoidable harm among adults with type 2 diabetes. Earlier studies of a sepsis alert system were small or single-centre.
Guidelines make only a weak recommendation on a sepsis alert system. health-related quality of life remains a leading cause of avoidable harm among adults with type 2 diabetes.
Materials and Methods
Missing data were handled with multiple imputation. Eligible participants were adults with type 2 diabetes.
Missing data were handled with multiple imputation. We conducted a systematic review and meta-analysis across 3 centres between 2020 and 2025.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were adults with type 2 diabetes. Missing data were handled with multiple imputation.
Analyses were adjusted for age, sex and baseline severity. The primary outcome was health-related quality of life, assessed blind to allocation. We conducted a systematic review and meta-analysis across 13 centres between 2018 and 2021.
Results
2099 participants were included (median age 65 years). Serious adverse events were rare and similar between groups. health-related quality of life occurred in 15% of the intervention group versus 32% of controls. Effects were consistent across prespecified subgroups.
2650 participants were included (median age 33 years). Effects were consistent across prespecified subgroups. 1341 participants were included (median age 75 years). 707 participants were included (median age 72 years).
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.60 (95% CI 0.46 to 0.75). 4397 participants were included (median age 39 years).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Control | 388 | 50 | 24.6 | 0.98 | 0.33–1.6 |
| Centre A | 177 | 55 | 39.6 | 0.81 | 0.31–1.39 |
| Female | 749 | 117 | 8.3 | 0.40 | 0.37–1.16 |
| Centre A | 467 | 95 | 36.7 | 0.76 | 0.20–1.8 |
| Age < 65 | 833 | 47 | 24.2 | 0.84 | 0.48–1.18 |
| Centre B | 417 | 80 | 36.9 | 0.50 | 0.53–1.11 |
Values are n (%) unless stated otherwise.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.70 (95% CI 0.40 to 0.85). 2367 participants were included (median age 33 years).
health-related quality of life occurred in 12% of the intervention group versus 29% of controls. The adjusted odds ratio was 0.42 (95% CI 0.48 to 0.63).
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Future work should test a sepsis alert system in a pragmatic multicentre trial. These findings suggest that a sepsis alert system is associated with better health-related quality of life in adults with type 2 diabetes. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Future work should test a sepsis alert system in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that a sepsis alert system is associated with better health-related quality of life in adults with type 2 diabetes.
Conclusions
A sepsis alert system merits wider use for adults with type 2 diabetes to improve health-related quality of life.
Appendices
The statistical analysis plan is in the online supplement.